Vaccines | Free Full-Text | Mucosal Vaccination Strategies against Clostridioides difficile Infection
New Clostridioides difficile vaccine on the horizon • healthcare-in-europe.com
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes | NEJM
Development of an Effective Nontoxigenic Clostridioides difficile–Based Oral Vaccine against C. difficile Infection | Microbiology Spectrum
Old C. difficile Vaccine Candidate MVX02 | matrivax
Clostridium difficile and One Health - ScienceDirect
A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile | BMC Infectious Diseases | Full Text
Frontiers | Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile
View PDF
Vaccines | Free Full-Text | Mucosal Vaccination Strategies against Clostridioides difficile Infection
Percentages of participants who achieved prespecified levels of toxin... | Download Scientific Diagram
Frontiers | Host Immune Responses to Clostridioides difficile: Toxins and Beyond
Chasing Sanofi, Pfizer tees up phase 3 trials for C. diff vaccine | Fierce Biotech
Emerging Vaccines for Clostridium difficile Infection Treatment
Synthetic Oligosaccharide-Based Vaccines Protect Mice from Clostridioides difficile Infections | ACS Chemical Biology
JCI Insight - Human C. difficile toxin–specific memory B cell repertoires encode poorly neutralizing antibodies
Vaccines | Free Full-Text | Mucosal Vaccination Strategies against Clostridioides difficile Infection
Synthetic Lipoteichoic Acid Glycans Are Potential Vaccine Candidates to Protect from Clostridium difficile Infections - ScienceDirect
C. difficile Vaccine Candidate MVX02 | matrivax
Frontiers in antibiotic alternatives for Clostridioides difficile infection
C. diff vaccine trial strikes one blow in bigger bug battle - UCHealth Today
Cytotoxic activity of purified toxins from prevalent C. difficile... | Download Table
Pfizer's C. Difficile Vaccine Misses Primary Endpoint in Trial
C. Diff Vaccine (high risk patients) – J. Lewis Research, Inc.
New Research Tests C. Difficile Vaccine Efficacy - Drexel University College of Medicine
In silico designing of vaccine candidate against Clostridium difficile | Scientific Reports
